Dynorphin A increases substance P release from trigeminal primary afferent C-fibers

European Journal of Pharmacology

Volumn 366, Issue 1, 1999, Pages 27-34

  Arcaya, José Luis ^a   Cano, Georgina ^a   Gómez, Gerber ^a   Maixner, William ^b   Suárez Roca, Heberto ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Dynorphin; NMDA receptor antagonist; Opioid receptor antagonist; Primary afferent; Substance P

Indexed keywords

BETA FUNALTREXAMINE; CAPSAICIN; DIZOCILPINE; DYNORPHIN A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONAZINE; NALOXONE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; SUBSTANCE P;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MUSCLE SPINDLE AFFERENT NERVE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SENSORY NERVE; SUBCUTANEOUS DRUG ADMINISTRATION; TRIGEMINAL NUCLEUS;

ANIMALS; ANIMALS, NEWBORN; CAPSAICIN; DIZOCILPINE MALEATE; DYNORPHINS; ENKEPHALIN, LEUCINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NERVE FIBERS; NEURONS, AFFERENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; SUBSTANCE P; TRIGEMINAL NUCLEI;

EID: 0032981277     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00897-8     Document Type: Article

References (39)

1. Aanonsen, L.M., Seybold, V.S., 1989. Phencyclidine and sigma receptors in rat spinal cord: binding characterization and quantitative autoradiography. Synapse 4, 1-10.
2. Caudle, R.M., Chavkin, C., Dubner, R., 1994. K2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. J. Neurosci. 14, 5580-5589.
3. Chen, L., Gu, Y., Huang, L.Y.M., 1995. The mechanism of action of NMDA receptor channels by the opioid peptide dynorphin. J. Neurosci. 15, 4602-4611.
4. Cox, B.M., Molineaux, C.J., Jacobs, T.P., Rossenberger, J.G., Faden, A.I., 1985. Effect of traumatic injury on dynorphin immunoreactivity in spinal cord. Neuropeptides 5, 571-574.
5. Cruz, L., Basbaum, A.I., 1985. Multiple opioid peptides and the modulation of pain: immunohistochemical analysis of dynorphin and enkephalin in the trigeminal nucleus caudalis and the spinal cord of the cat. J. Comp. Neurol. 240, 331-348.
6. Cuesta, M.C., Suarez-Roca, H., Arcaya, J.L., Cano, G., Gomez, G., Maixner, W., 1996. Opposite modulation of capsaicin-evoked substance P release from trigeminal slices by subtype selective glutamate receptor agonists. Neurosci. Abstr. 22, 875, Abstract.
7. Draisci, G., Kajander, K.C., Dubner, R., Bennett, G.J., Iadarola, M.J., 1991. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 560, 186-192.
8. Fujimoto, J.M., Holmes, B., 1990. Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17). J. Pharmacol. Exp. Ther. 254 (1), 1-7.
9. Fujimoto, J.M., Arts, K.S., Rady, J.J., Tseng, L.F., 1990. Spinal dynorphin A (1-17): possible mediator of antianalgesic action. Neuropharmacology 29, 609-617.
10. Fuxe, K., Agnati, L.F., Zoli, M., Cintra, A., Harfstrand, A., Von Euler, G., Grimaldi, R., Kalia, M., Eneroth, P., 1988. The opioid peptide systems: their organization and role in volume transmission and neuroendocrine regulation. In: Iles, P., Farsang, C. (Eds.), Regulatory Role of Opioid Peptides. V.C.H. Weinhein, FRG, 33.
11. Gamse, R., Leeman, S.E., Holzer, P., Lembeck, F., 1981. Differential effects of capsaicin on the content of somatostatin substance P and neurotensin in the nervous system of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 317, 140-148.
12. Hökfelt, T., Ljungdahl, A., Terenius, L., Elde, R., Nilson, G., 1977. Immunohistochemical analysis of peptide pathways posible related to pain and analgesia: Enkephalin and substance P. P.N.A.S. 74, 3081-3085.
13. Hunter, W.M., Greenwood, F.C., 1962. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194, 495-496.
14. Iadarola, M.J., Ruda, M.A., Cohen, L.V., Flores, C.M., Naranjo, J.R., 1988. Enhanced dynorphin gene expression in spinal cord dorsal horn neurons during peripheral inflammation: behavioral, neuropeptide, immunocytochemical and mRNA studies. In: Dubner, R., Gebhart, G.F., Bond, M.R. (Eds.), Proceedings of the 5th World Congress on Pain. Elsevier, Biomedical Division, Amsterdam, 61.
15. Jancso, G., Kiraly, E., 1980. Distribution of chemosensitive primary sensory afferent neurons in the rat CNS. J. Comp. Neurol. 190, 781-792.
16. Knox, R.J., Dickenson, A.H., 1987. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre evoked responses of rat dorsal horn neurons. Brain Res. 415, 21-29.
17. Laulin, J.P., Larcher, A., Celerier, E., Lemoal, M., Simonnet, G., 1996. Pain facilitation induced by opioid opposing process blocked by NMDA antagonist MK 801. Neurosci. Abstr. 22, 1363.
18. Liu, H., Wang, H., Sheng, M., Jan, L.Y., Jan, Y.N., Basbaum, A.I., 1994. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. P.N.A.S. 91, 8383-8387.
19. Massardier, D., Hunt, P.F., 1989. A direct non-opioid interaction of dynorphin (1-13) with N-methyl-D-aspartate (NMDA) receptor. Eur. J. Pharmacol. 170, 125-126.
20. Nagy, J.I., Hunt, S.P., Iversen, L.L., Emson, P.C., 1981. Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience 6, 1923-1934.
21. Nagy, J.I., Iversen, L.L., Goedert, M., Chapman, D., Hunt, S.P., 1983. Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J. Neurosci. 3, 399-406.
22. Nahin, R.L., Hylden, J.L., Humphrey, 1992. Demostration of dynorphin A 1-8 immunoreactive axons contacting spinal cord projection neurons in a rat model of peripheral inflammation and hyperalgesia. Pain 51, 135-143.
23. Rady, J.J., Fujimoto, J.M., Tseng, L.F., 1991. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors. J. Pharmacol. Exp. Ther. 259, 1073-1080.
24. Riley, R.C., Zhao, Z.Q., Duggan, A.W., 1996. Spinal release of immunoreactive dynorphin A(1-8) with the development of peripheral inflammation in the rat. Brain Res. 710, 131-142.
25. Rothman, R.B., Bykov, V., De Costa, B.R., Jacobson, A.E., Rice, K.C., Brady, L.S., 1990. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides 11, 311-331.
26. 3H]cycloFoxy binding in rat brain: further evidence that β-FNA alkilates the opioid receptor complex. Synapse 8, 86-89.
27. Schmauss, C., Hertz, A., 1987. Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats. Eur. J. Pharmacol. 135, 429-431.
28. Shen, K.-F., Crain, S.M., 1990. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance. Neuropharmacology 29, 343-349.
29. Shukla, V.K., Lemaire, S., 1994. Non-opioid effects of dynorphins: posible role of the NMDA receptor. T.I.P.S. 15, 420-424.
30. Standaert, D.G., Watson, S.J., Houghten, K.A., Saper, C.B., 1986. Opioid peptide immunoreactivity in spinal cord and trigeminal dorsal horn neurons projecting to the parabrachial nucleus in the rat. J. Neurosci. 6, 1220-1226.
31. Stevens, C., Yaksh, T., 1986. Dynorphin A and related peptides administered intrathecal in the rat: a search for putative kappa opioid receptor activity. J. Pharmacol. Exp. Ther. 238, 833-838.
32. Suarez-Roca, H., Maixner, W., 1992. Morphine produces a multiphasic effect on substance P release from trigeminal nucleus caudalis slices by activating different opioid receptor subtypes. Brain Res. 579, 195-203.
33. Suarez-Roca, H., Maixner, W., 1993. Activation of kappa receptors by U50,488H and morphine enhances release of substance P from rat trigeminal nucleus slices. J. Pharmacol. Exp. Ther. 264, 648-653.
34. Suarez-Roca, H., Cano, G., Arcaya, J.L., Gomez, G., Maixner, W., 1996. Neonatal capsaicin abolishes morphine's multiphasic effect on substance P release from rat trigeminal slices. Neurosci. Abstr. 22, 118, (Abstract).
35. Takahashi, O., Traub, R.J., Ruda, M.A., 1988. Demostration of calcitonin gene-related peptide immunoreactive axons containing dynorphin A(1-8) immunoreactive spinal neurons in a rat model of peripheral inflammation and hyperalgesia. Brain Res. 475, 168-172.
36. Urban, L., Dray, L., 1992. Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro. Neurosci. Lett. 134, 9-11.
37. Vanderah, T.W., Laughlin, T., Lashbrook, J.M., Nichols, M.L., Wilcox, G.L., Ossipov, M.H., Malan, T.P., Porreca, F., 1996. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long lasting allodynia in rats: blockade by MK-801 but not by naloxone. Pain 68, 275-281.
38. Wong, E.H., Kemp, J.A., Priestley, T., Knight, A.R., Woodruff, G.N., Iversen, L.L., 1986. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. P.N.A.S. 83, 7104-7108.
39. Yakovlev, A.G., Faden, A.I., 1994. Sequential expression of c-fos protooncogene, TNF-alfa, and dynorphin genes in spinal cord following experimental traumatic injury. Mol. Chem. Neuropathol. 23, 179-190.